Pathophysiological Role of Extracellular Purinergic Mediators in the Control of Intestinal Inflammation

Abstract EN

Purinergic mediators such as adenosine 5′-triphosphate (ATP) are released into the extracellular compartment from damaged tissues and activated immune cells.

They are then recognized by multiple purinergic P2X and P2Y receptors.

Release and recognition of extracellular ATP are associated with both the development and the resolution of inflammation and infection.

Accumulating evidence has recently suggested the potential of purinergic receptors as novel targets for drugs for treating intestinal disorders, including intestinal inflammation and irritable bowel syndrome.

In this review, we highlight recent findings regarding the pathophysiological role of purinergic mediators in the development of intestinal inflammation.